A relaxed discussion between two faculty focussed on real world clinical issues. Useful tips below will show how to navigate the activity. Join the conversation.
Maximizing the potential of PARP inhibitors as first-line maintenance therapy in ovarian cancer: Improving patient identification and treatment selection
After watching this activity, participants should be better able to:
- Discuss the rationale for using PARP inhibitors in the first-line maintenance treatment of advanced ovarian cancer
- Identify patients who may benefit from a PARP inhibitor in the first-line maintenance setting
- Describe the key factors that can inform selection of the most appropriate PARP inhibitor for each patient
In this activity, gynaecologic oncology specialists Prof. Nicoletta Colombo and Dr Natalia R Gómez-Hidalgo discuss three key topics relating to PARP inhibitors in the first-line maintenance setting for advanced ovarian cancer – rationale for use, which patients may particularly benefit, and key factors informing PARP inhibitor selection. Discussion on these themes is based on questions posed by healthcare professionals involved in the care of patients with ovarian cancer.
To obtain the CE credit(s) from this activity, please complete this post-activity test.Claim Credit
You may also be interested in...
Keiichi Fujiwara, ESMO 2022: Phase 3 GOTIC-002 LUFT study results – Chemotherapy with tegafur-uracil for locally advanced cervical cancer
Pembrolizumab and Chemotherapy in Cervical Cancer: A New Standard of Care?
Shifting the focus to locally advanced cervical cancer: Improving patient outcomes through multidisciplinary teamworkThis activity is CE/CME accredited
High-risk Endometrial Cancer: The Present and Future of Adjuvant Therapy
The evolving clinical landscape of biologic therapy for patients with recurrent/metastatic cervical cancerThis activity is CE/CME accredited
Gloria Huang, ASCO 2019 – NRG Oncology/Gynecologic Oncology Group 210 trial
Register to touchONCOLOGY for FREE
- Peer-reviewed journals and expert opinions
- Interactive CME and e-learning modules
- Video conference highlights
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGYSign me up!